About Sunlovis Pharmaceuticals LLP
The company has 36 employees. Sunlovis Pharmaceuticals LLP offers products and services including Tablets and Injectables.
- Employees 36
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social Facebook
- Legal Name Sunlovis Pharmaceuticals Llp
- Date of Incorporation 20 Mar, 2017
- Jurisdiction Hajipur, Gujarat, India
- Annual Revenue₹38.38 Cr
FY 2024 · +41% YoY
- Net Profit₹72.9 Lakh
FY 2024 · 2% margin
- EBITDA₹3.09 Cr
FY 2024 · 8% margin
- Employee Count36
Associated legal entities of Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals LLP operates through Sunlovis Pharmaceuticals Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sunlovis Pharmaceuticals Llp CIN AAI-8723 | Active | 20 Mar 2017 | Hajipur, Gujarat | ₹38.4 Cr | 29 | 6 | View details |
Products & Services of Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals LLP offers a comprehensive portfolio of products and services, including Tablets and Injectables.
Tablets are manufactured for addressing various health requirements in the pharmaceutical sector.
Injectables are produced to support medical treatments and are offered as part of the company's range.
Board of directors of Sunlovis Pharmaceuticals Llp (Sunlovis Pharmaceuticals LLP)
Sunlovis Pharmaceuticals Llp is the primary company behind Sunlovis Pharmaceuticals LLP. The board of Sunlovis Pharmaceuticals Llp currently have 6 directors; the longest-serving is Pravinbhai Ramsangbhai Chaudhari, appointed in 2017. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pravinbhai Ramsangbhai Chaudhari DIN 02903893 | Designated Partner | 20 Mar 2017 | 9 yrs 6 mo | Sunlovis Pharmaceuticals Llp |
| Vijaykumar Madhabhai Chaudhari DIN 07751308 | Designated Partner | 20 Mar 2017 | 9 yrs 6 mo | Sunlovis Pharmaceuticals Llp |
| Yogesh Babubhai Chaudhary DIN 07751373 | Designated Partner | 20 Mar 2017 | 9 yrs 6 mo | Sunlovis Pharmaceuticals Llp |
| Babulal Manilal Chaudhary DIN 07725352 | Designated Partner | 20 Mar 2017 | 9 yrs 6 mo | Sunlovis Pharmaceuticals Llp |
| Vipulkumar Babubhai Chaudhari DIN 07587962 | Designated Partner | 20 Mar 2017 | 9 yrs 6 mo | Sunlovis Pharmaceuticals Llp |
| Pravinkumar Hemtabhai Chaudhary DIN 05112175 | Designated Partner | 11 May 2021 | 5 yrs 5 mo | Sunlovis Pharmaceuticals Llp |
Financials of Sunlovis Pharmaceuticals LLP
Figures of Sunlovis Pharmaceuticals Llp, the primary company behind Sunlovis Pharmaceuticals LLP, for FY 2024. Revenue was ₹38.38 Cr (+41% year on year). Net profit was ₹72.9 Lakh (2% margin). EBITDA was ₹3.09 Cr (8% margin). Revenue has grown at a compounded annual rate of +20% over three years and +52% over five years.
- ₹38.38 CrRevenue · FY 2024 · +41% YoY
- ₹72.9 LakhNet profit · 2% margin
- ₹3.09 CrEBITDA · 8% margin
- 29Employees (provident fund records)
- +20%Revenue CAGR, 3 years
- +52%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sunlovis Pharmaceuticals Llp are on its company page.
Detailed financial statements for Sunlovis Pharmaceuticals LLP
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Sunlovis Pharmaceuticals LLP
10 companies that operate in the same segment as Sunlovis Pharmaceuticals LLP (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sunlovis Pharmaceuticals LLP
Sunlovis Pharmaceuticals LLP has 36 employees.
The primary company behind Sunlovis Pharmaceuticals LLP, Sunlovis Pharmaceuticals Llp, reported revenue of ₹38.38 Cr for FY 2024, up 41% year on year.
Sunlovis Pharmaceuticals LLP is known for its manufacturing of a diverse array of pharmaceutical products, including tablets, capsules, and injectables, which are produced in a WHO-GMP certified facility located in Gujarat, India. Quality standards are maintained through stringent processes, and customer needs are addressed by developing innovative solutions. The companys commitment to global benchmarks is evident in its certifications and focus on cost-effective healthcare offerings. Products such as suspensions and ointments are created to meet essential health demands, while services emphasize flexibility and technology integration for better outcomes.
Sunlovis Pharmaceuticals LLP offers Tablets and Injectables.
Sunlovis Pharmaceuticals LLP operates through Sunlovis Pharmaceuticals Llp.
The legal entities of Sunlovis Pharmaceuticals LLP currently have 6 directors, including Pravinbhai Ramsangbhai Chaudhari, Pravinkumar Hemtabhai Chaudhary, Vijaykumar Madhabhai Chaudhari and others.